Abstract
Neurodegenerative diseases (NDs) are a group of neurological diseases caused by the progressive degeneration of neurons and glial cells in the brain and spinal cords. Usually there is a selective loss of specific neuronal cells in a restricted brain area from any neurodegenerative diseases, such as dopamine (DA) neuron death in Parkinson disease (PD) and motor neuron loss in amyotrophic lateral sclerosis (ALS), or a widespread degeneration affecting many types of neurons in Alzheimer’s disease (AD). As there is no effective treatment to stop the progression of these neurodegenerative diseases, stem cell–based therapies have provided great potentials for these disorders. Currently transplantation of different stem cells or their derivatives has improved neural function in animal models of neurodegenerative diseases by replacing the lost neural cells, releasing cytokines, modulation of inflammation, and mediating remyelination. With the advance in somatic cell reprogramming to generate induced pluripotent stem cells (iPS cells) and directly induced neural stem cells or neurons, pluripotent stem cell can be induced to differentiate to any kind of neural cells and overcome the immune rejection of the allogeneic transplantation. Recent studies have proved the effectiveness of transplanted stem cells in animal studies and some clinical trials on patients with NDs. However, some significant hurdles need to be resolved before these preclinical results can be translated to clinic. In particular, we need to better understand the molecular mechanisms of stem cell transplantation and develop new approaches to increase the directed neural differentiation, migration, survival, and functional connections of transplanted stem cells in the pathological environment of the patient’s central nerve system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
N. Abi Chahine, T. Wehbe, J. Rashed, R. Hilal, N. Elias, Autologous bone marrow derived stem cells for the treatment of multiple sclerosis. Int. J. Stem Cells 9(2), 207–212 (2016)
B.R. Achyut, N.R. Varma, A.S. Arbab, Application of umbilical cord blood derived stem cells in diseases of the nervous system. J. Stem Cell Res. Ther. 2014, 4 (2014)
H. Akiyama, P.L. McGeer, S. Itagaki, E.G. McGeer, T. Kaneko, Loss of glutaminase-positive cortical neurons in Alzheimer’s disease. Neurochem. Res. 14(4), 353–358 (1989)
E. Anitua, M. Troya, M. Zalduendo, Progress in the use of dental pulp stem cells in regenerative medicine. Cytotherapy 18, 30003–30003 (2018). https://doi.org/10.1016/j.jcyt.2017.12.011. [Epub ahead of print]. Review. pii: S1465–3249
C. Badja, G. Maleeva, C. El-Yazidi, E. Barruet, M. Lasserre, P. Tropel, B. Binetruy, P. Bregestovski, F. Magdinier, Efficient and cost-effective generation of mature neurons from human induced pluripotent stem cells. Stem Cells Transl. Med. 3(12), 1467–1472 (2014)
R.A. Barker, I. de Beaufort, Scientific and ethical issues related to stem cell research and interventions in neurodegenerative disorders of the brain. Prog Neurobiol 110, 63–73 (2013). https://doi.org/10.1016/j.pneurobio.2013.04.003. Epub 2013 May 7.
R.A. Barker, M. Gotz, M. Parmar, New approaches for brain repair-from rescue to reprogramming. Nature 557, 329–334 (2018)
A.K. Batsali, M.C. Kastrinaki, H.A. Papadaki, C. Pontikoglou, Mesenchymal stem cells derived from Wharton’s jelly of the umbilical cord: biological properties and emerging clinical applications. Curr. Stem Cell Res. Ther. 8, 144–155 (2013)
A.M. Bond, G.L. Ming, H. Song, Adult mammalian neural stem cells and neurogenesis: five decades later. Cell Stem Cell 17, 385–395 (2015)
R. Cacabelos, Parkinson’s disease: from pathogenesis to pharmacogenomics. Int. J. Mol. Sci. 18(3), E551 (2017)
T.M. Dawson, T.E. Golde, C. Lagier-Tourenne, Animal models of neurodegenerative diseases. Nat. Neurosci. 21(10), 1370–1379 (2018)
D. Trudler, S.A. Lipton, Novel direct conversion of microglia to neurons. Trends Mol. Med. 25(2), 72–74 (2019)
M.G. Erkkinen, M.O. Kim, M.D. Geschwind, Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 10(4), a033118 (2018). https://doi.org/10.1101/cshperspect.a033118
S. Frere, I. Slutsky, Alzheimer’s disease: from firing instability to homeostasis network collapse. Neuron 97(1), 32–58 (2018)
H. Fu, J. Hardy, K.E. Duff, Selective vulnerability in neurodegenerative diseases. Nat. Neurosci. 21, 1350–1358 (2018)
F.H. Gage, S. Temple, Neural stem cells: generating and regenerating the brain. Neuron 80(3), 588–601 (2013)
S. Gascón, G. Masserdotti, G.L. Russo, M. Götz, Direct neuronal reprogramming: achievements, hurdles, and new roads to success. Cell Stem Cell 21(1), 18–34 (2017)
S. Grade, M. Götz, Neuronal replacement therapy: previous achievements and challenges ahead. NPJ Regen. Med. 2, 29 (2017)
F. Han, C. Chen, W. Wang, H. Song, S. Li, J. Duan, X. Lu, S. Wu, N. Zhang, Q. Chen, Human umbilical cord-derived mesenchymal stromal cells ameliorated motor defects of 6-OHDA-induced rat model of Parkinson’s disease. Oncotarget 8, 19 (2018)
F. Han, W. Wang, B. Chen, C. Chen, S. Li, X. Lu, J. Duan, Y. Zhang, Y.A. Zhang, W. Guo, et al., Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson’s disease. Cytotherapy 17, 665–679 (2015a)
F. Han, W. Wang, C. Chen, Research progress in animal models and stem cell therapy for Alzheimer’s disease. J. Neurorestoratol 3, 11–22 (2015b)
O. Hardiman, A. Al-Chalabi, A. Chio, E.M. Corr, G. Logroscino, W. Robberecht, P.J. Shaw, Z. Simmons, L.H. van den Berg, Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 3, 17071 (2017)
H.M. Blau, G.Q. Daley, Stem cells in the treatment of disease. N. Engl. J. Med. 380(18), 1748–1760 (2019)
W.J. Huang, W.W. Chen, X. Zhang, Multiple sclerosis: pathology, diagnosis and treatments. Exp. Ther. Med. 13(6), 3163–3166 (2017)
J. Shin, D.A. Berg, Y. Zhu, J.Y. Shin, J. Song, M.A. Bonaguidi, G. Enikolopov, D.W. Nauen, K.M. Christian, G.-l. Ming, H. Song, Single-cell RNA-seq with waterfall reveals molecular cascades underlying adult neurogenesis. Cell Stem Cell 17(3), 360–372 (2015)
I.E. Jansen, J.E. Savage, K. Watanabe, J. Bryois, D.M. Williams, S. Steinberg, J. Sealock, I.K. Karlsson, S. Hagg, L. Athanasiu, et al., Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat. Genet. 51, 404–413 (2019)
M. Li, A.E. Rosser, Pluripotent stem cell-derived neurons for transplantation in Huntington’s disease. Prog. Brain Res. 230, 263–281 (2017)
M.R. Livesey, D. Magnani, G.E. Hardingham, S. Chandran, D.J. Wyllie, Functional properties of in vitro excitatory cortical neurons derived from human pluripotent stem cells. J. Physiol. 594(22), 6573–6582 (2016)
J. Lu, X. Zhong, H. Liu, L. Hao, C.T. Huang, M.A. Sherafat, J. Jones, M. Ayala, L. Li, S.C. Zhang, Generation of serotonin neurons from human pluripotent stem cells. Nat. Biotechnol. 34(1), 89–94 (2016)
P. Lu, Y. Wang, L. Graham, K. McHale, M. Gao, D. Wu, J. Brock, A. Blesch, E.S. Rosenzweig, L.A. Havton, et al., Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 150, 1264–1273 (2012)
R.E. MacLaren, R.A. Pearson, A. MacNeil, R.H. Douglas, T.E. Salt, M. Akimoto, A. Swaroop, J.C. Sowden, R.R. Ali, Retinal repair by transplantation of photoreceptor precursors. Nature 444, 203–207 (2006)
M. Mandai, A. Watanabe, Y. Kurimoto, Y. Hirami, C. Morinaga, T. Daimon, M. Fujihara, H. Akimaru, N. Sakai, Y. Shibata, M. Terada, Y. Nomiya, S. Tanishima, M. Nakamura, H. Kamao, S. Sugita, A. Onishi, T. Ito, K. Fujita, S. Kawamata, M.J. Go, C. Shinohara, K.-I. Hata, M. Sawada, M. Yamamoto, S. Ohta, Y. Ohara, K. Yoshida, J. Kuwahara, Y. Kitano, N. Amano, M. Umekage, F. Kitaoka, A. Tanaka, C. Okada, N. Takasu, S. Ogawa, S. Yamanaka, M. Takahashi, Autologous induced stem-cell-derived retinal cells for macular degeneration. N. Engl. J. Med. 376(11), 1038–1046 (2017)
G. Martello, A. Smith, The nature of embryonic stem cells. Annu. Rev. Cell Dev. Biol. 30, 647–675 (2014)
M. Mayer-Proschel, A.J. Kalyani, T. Mujtaba, M.S. Rao, Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron 19, 773–785 (1997)
S. Méndez-Ferrer, D.T. Scadden, A. Sánchez-Aguilera, Bone marrow stem cells: current and emerging concepts. Ann. N. Y. Acad. Sci. 1335, 32–44 (2015)
E.J. Mufson, S.Y. Ma, E.J. Cochran, D.A. Bennett, L.A. Beckett, S. Jaffar, H.U. Saragovi, J.H. Kordower, Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer’s disease. J. Comp. Neurol. 427(1), 19–30 (2000)
L.A. Nash, J.K. Burns, J.W. Chardon, R. Kothary, R.J. Parks, Spinal muscular atrophy: more than a disease of motor neurons? Curr. Mol. Med. 16(9), 779–792 (2016)
H. Nazari, L. Zhang, D. Zhu, G.J. Chader, P. Falabella, F. Stefanini, T. Rowland, D.O. Clegg, A.H. Kashani, D.R. Hinton, M.S. Humayun, Stem cell based therapies for age-related macular degeneration: the promises and the challenges. Prog. Retin. Eye Res. 48, 1–39 (2015)
T.M. Osborn, P.J. Hallett, J.M. Schumacher, O. Isacson, Advantages and recent developments of autologous cell therapy for Parkinson’s disease patients. Front. Cell. Neurosci. 14, 58 (2020)
G.A. Pilz, S. Bottes, M. Betizeau, D.J. Jörg, S. Carta, B.D. Simons, F. Helmchen, S. Jessberger, Live imaging of neurogenesis in the adult mouse hippocampus. Science 359(6376), 658–662 (2018)
M.S. Rao, M. Mayer-Proschel, Glial-restricted precursors are derived from multipotent neuroepithelial stem cells. Dev. Biol. 188, 48–63 (1997)
U. Rüb, K. Seidel, H. Heinsen, J.P. Vonsattel, W.F. den Dunnen, H.W. Korf, Huntington’s disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain. Brain Pathol. 26(6), 726–740 (2016)
V. Silva-Vargas, E.E. Crouch, F. Doetsch, Adult neural stem cells and their niche: a dynamic duo during homeostasis, regeneration, and aging. Curr. Opin. Neurobiol. 23(6), 935–942 (2013)
F. Simonacci, N. Bertozzi, E. Raposio, Off-label use of adipose-derived stem cells. Ann. Med. Surg. (Lond). 24, 44–51 (2017)
K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, S. Yamanaka, Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007)
Y. Tao, S.C. Zhang, Neural subtype specification from human pluripotent stem cells. Cell Stem Cell 19, 573–586 (2016)
J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, J.M. Jones, Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998)
O. Trohatou, M.G. Roubelakis, Mesenchymal stem/stromal cells in regenerative medicine: past, present, and future. Cell. Reprogram. 19(4), 217–224 (2017)
A. Uccelli, F. Benvenuto, A. Laroni, D. Giunti, Neuroprotective features of mesenchymal stem cells. Best Pract. Res. Clin. Haematol. 24(1), 59–64 (2011)
G. Upadhyay, S. Shankar, R.K. Srivastava, Stem cells in neurological disorders: emerging therapy with stunning hopes. Mol. Neurobiol. 52(1), 610–625 (2015)
K.C. Vadodaria, M.C. Marchetto, J. Mertens, F.H. Gage, Generating human serotonergic neurons in vitro: methodological advances. BioEssays 38(11), 1123–1129 (2016)
R. Volkman, D. Offen, Concise review: mesenchymal stem cells in neurodegenerative diseases. Stem Cells 35(8), 1867–1880 (2017)
J.D. Welch, V. Kozareva, A. Ferreira, C. Vanderburg, C. Martin, E.Z. Macosko, Single-cell multi-omic integration compares and contrasts features of brain cell identity. Cell 177(1873–1887), e1817 (2019)
K.J. Wert, J.H. Lin, S.H. Tsang, General pathophysiology in retinal degeneration. Dev. Ophthalmol. 53, 33–43 (2014)
Z. Xu, X. Chu, H. Jiang, H. Schilling, S. Chen, J. Feng, Induced dopaminergic neurons: A new promise for Parkinson’s disease. Redox Biol. 11, 606–612 (2017)
N. Zhang, B. Chen, W. Wang, C. Chen, J. Kang, S.Q. Deng, B. Zhang, S. Liu, F. Han, Isolation, characterization and multi-lineage differentiation of stem cells from human exfoliated deciduous teeth. Mol. Med. Rep. 14, 95–102 (2016)
N. Zhang, X. Lu, S. Wu, X. Li, J. Duan, C. Chen, W. Wang, H. Song, J. Tong, S. Li, et al., Intrastriatal transplantation of stem cells from human exfoliated deciduous teeth reduces motor defects in Parkinsonian rats. Cytotherapy 20, 670–686 (2018)
Acknowledgments
This work was supported by National Natural Science Foundation of China (NSFC 81571241), Department of Science and technology of Shandong Province, China (2017GSF18104), and Basic Research fund from Natural Science Foundation of Shandong Province, China (ZR2019ZD39). Merit Review Award Number I01 RX002264-01A2 from the United States (U.S.) And Department of Veterans Affairs Rehabilitation Research and Development (RR&D) Service and NIH (R21 NS103074-01). We also thank Wei Wang, Nan Zhang, Xianjie Lu, Jing Duan, Na Song, Yan Wang, Li Xu and Yanming Liu in our lab for their technically editing the references and making figures of all the manuscripts.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Han, F., Lu, P. (2020). Introduction for Stem Cell–Based Therapy for Neurodegenerative Diseases. In: Han, F., Lu, P.(. (eds) Stem Cell-based Therapy for Neurodegenerative Diseases. Advances in Experimental Medicine and Biology, vol 1266. Springer, Singapore. https://doi.org/10.1007/978-981-15-4370-8_1
Download citation
DOI: https://doi.org/10.1007/978-981-15-4370-8_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-4369-2
Online ISBN: 978-981-15-4370-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)